Processes for forming a drug delivery device
First Claim
1. A method of making a drug delivery device comprising co-extruding an inner drug-containing core and at least one outer polymeric skin that at least partially surrounds the core.
4 Assignments
0 Petitions
Accused Products
Abstract
A drug delivery device can, in whole or in part, be formed by co-extruding a drug core and an outer tube. The outer tube may be permeable, semi-permeable, or impermeable to the drug. The drug core may include a polymer matrix which does not significantly affect the release rate of the drug. The outer tube, the polymer matrix of the drug core, or both may be bioerodible. The co-extruded product can be segmented into drug delivery devices. The devices may be left uncoated so that their respective ends are open, or the devices may be coated with, for example, a layer that is permeable to the drug, semi-permeable to the drug, or bioerodible.
166 Citations
45 Claims
- 1. A method of making a drug delivery device comprising co-extruding an inner drug-containing core and at least one outer polymeric skin that at least partially surrounds the core.
-
21. A method of making a drug delivery device comprising:
-
(a) forwarding a polymeric material to a first extrusion device;
(b) forwarding a drug to a second extrusion device;
(c) co-extruding a mass including the polymeric material and the drug; and
(d) forming the mass into at least one co-extruded drug delivery device which comprises a core including the drug and an outer layer including the polymeric material. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)
-
-
43. A device for fabricating an implantable drug delivery device comprising:
-
(a) a first extruder for extruding a core, wherein the core includes at least one drug; and
(b) a second extruder for extruding a skin, wherein the skin is disposed about the core to form a co-extruded material, and wherein the skin has at least one of a permeability or an erodibility selected to control the release rate of the drug in a device formed from a segment of the co-extruded material. - View Dependent Claims (44, 45)
-
Specification